Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Pharmacol Rep ; 61(2): 311-8, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19443944

RESUMEN

To assess the possible modulatory effects of noradrenergic and serotoninergic neurons on dopaminergic neuronal activity, the noradrenergic and serotoninergic neurotoxins DSP-4 N-(2-chlorethyl)-N-ethyl-2-bromobenzylamine (50.0 mg/kg, sc) and 5,7-dihydroxytryptamine (5,7-DHT) (37.5 microg icv, half in each lateral ventricle), respectively, were administered toWistar rats on the first and third days of postnatal ontogeny, and dopamine (DA) agonist-induced behaviors were assessed in adulthood. At eight weeks, using an HPLC/ED technique, DSP-4 treatment was associated with a reduction in NE content of the corpus striatum (> 60%), hippocampus (95%), and frontal cortex (> 85%), while 5,7-DHT was associated with an 80-90% serotonin reduction in the same brain regions. DA content was unaltered in the striatum and the cortex. In the group lesioned with both DSP-4 and 5,7-DHT, quinpirole-induced (DA D(2) agonist) yawning, 7-hydroxy-DPAT-induced (DA D(3) agonist) yawning, and apomorphine-induced (non-selective DA agonist) stereotypies were enhanced. However, SKF 38393-induced (DA D(1) agonist) oral activity was reduced in the DSP-4 + 5,7-DHT group. These findings demonstrate that DA D(2)- and D(3)-agonist-induced behaviors are enhanced while DA D(1)-agonist-induced behaviors are suppressed in adult rats in which brain noradrenergic and serotoninergic innervation of the brain has largely been destroyed. This study indicates that noradrenergic and serotoninergic neurons have a great impact on the development of DA receptor reactivity (sensitivity).


Asunto(s)
5,7-Dihidroxitriptamina/toxicidad , Conducta Animal/efectos de los fármacos , Bencilaminas/toxicidad , Agonistas de Dopamina/farmacología , Receptores de Dopamina D2/agonistas , Animales , Animales Recién Nacidos , Conducta Exploratoria/efectos de los fármacos , Masculino , Actividad Motora/efectos de los fármacos , Norepinefrina/fisiología , Quinpirol/farmacología , Ratas , Ratas Wistar , Receptores de Dopamina D2/fisiología , Serotonina/fisiología
2.
Pharmacol Rep ; 60(3): 331-8, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18622057

RESUMEN

To study the influence of the central noradrenergic system on sensitivity to sedative-hypnotic effects mediated by the aminobutyric acid (GABA) system, intact rats were contrasted with rats in which noradrenergic nerves were largely destroyed shortly after birth with the neurotoxin DSP-4 [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine; 50 mg/kg sc x2, P1 and P3]. At 10 weeks, loss of the righting reflex (LORR) was used as an index to study the acute sedative-hypnotic effects of phenobarbital (100 mg/kg ip) and ethanol (4 g/kg ip, 25% v/v). Additionally, GABA concentration in the medial prefrontal cortex (PFC), hippocampus, cerebellum and brainstem was estimated by an HPLC/ED method. Neonatal DSP-4 treatment diminished the sedative-hypnotic effects of both phenobarbital and ethanol in adult rats. While the endogenous GABA content in the PFC, hippocampus, brainstem and cerebellum of DSP-4-treated rats was not altered, phenobarbital significantly decreased GABA content of both intact and DSP-4-lesioned rats by approximately 40% in the hippocampus and by approximately 20% in other brain regions at 1 h. Ethanol reduced GABA content by approximately 15-30% but only in the hippocampus and brainstem of both intact and lesioned rats. These findings indicate that the noradrenergic system exerts a prominent influence on sedative-hypnotics acting via GABAergic systems in the brain without directly altering GABA levels in the brain.


Asunto(s)
Bencilaminas/farmacología , Etanol/farmacología , Fenobarbital/farmacología , Ácido gamma-Aminobutírico/metabolismo , Factores de Edad , Animales , Animales Recién Nacidos , Bencilaminas/administración & dosificación , Aminas Biogénicas/metabolismo , Tronco Encefálico/efectos de los fármacos , Tronco Encefálico/metabolismo , Depresores del Sistema Nervioso Central/administración & dosificación , Depresores del Sistema Nervioso Central/farmacología , Cerebelo/efectos de los fármacos , Cerebelo/metabolismo , Dopamina/metabolismo , Etanol/administración & dosificación , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Hipnóticos y Sedantes/administración & dosificación , Hipnóticos y Sedantes/farmacología , Inyecciones Intraperitoneales , Inyecciones Subcutáneas , Metoxihidroxifenilglicol/metabolismo , Inhibidores de la Captación de Neurotransmisores/administración & dosificación , Inhibidores de la Captación de Neurotransmisores/farmacología , Fenobarbital/administración & dosificación , Corteza Prefrontal/efectos de los fármacos , Corteza Prefrontal/metabolismo , Ratas , Ratas Wistar , Sueño/efectos de los fármacos , Sueño/fisiología , Factores de Tiempo
3.
Neurotoxicol Teratol ; 30(5): 428-32, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18430546

RESUMEN

It is well established that low level Pb-exposure is associated with a wide range of cognitive and neurobehavioral dysfunctions in children. In fact, Pb-induced damage occurs preferentially in the prefrontal cerebral cortex, hippocampus and cerebellum - the anatomical sites which are crucial in modulating emotional response, memory and learning. Previously it was also shown that nitric oxide (NO) signaling pathway as well as glutamatergic neurotransmission are both involved in brain development, neurotoxicity and neurodegeneration processes whereas Pb(2+) interfere with both. For this reason we investigated the effect of ontogenetic Pb(2+) exposure on dopaminergic neurotransmission in the medial prefrontal cortex (mPFC) of rats after amphetamine (AMPH) and/or 7-nitroindazole (7-NI) administration. Furthermore, the possible role of oxidative stress in Pb(2+)-induced neurotoxicity in prenatally Pb(2+)-treated rats was explored in the content of hydroxyl radical (HO) species in mPFC after AMPH and/or 7-NI injection, assessed by HPLC analysis of 2.3-dihydroxybenzoic acid (2.3-DHBA) - spin trap product of salicylate. As shown, the results of this study suggest that Pb(2+) exposure during intrauterine life did not substantially affect cortical dopaminergic neurotransmission in adult offspring rats evaluated by means of microdialysis of mPFC and the content of the cortical HO. It is likely that striatum, nucleus accumbens or other dopamine rich brain areas are more intricately associated with Pb(2+) precipitated behavioral, dopamine - dependent impairments observed in mammalians.


Asunto(s)
Corteza Cerebral/efectos de los fármacos , Dopamina/metabolismo , Intoxicación del Sistema Nervioso por Plomo/metabolismo , Plomo/toxicidad , Estrés Oxidativo/efectos de los fármacos , Efectos Tardíos de la Exposición Prenatal/metabolismo , Anfetamina/toxicidad , Animales , Estimulantes del Sistema Nervioso Central/toxicidad , Corteza Cerebral/metabolismo , Corteza Cerebral/fisiopatología , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/metabolismo , Cuerpo Estriado/fisiopatología , Modelos Animales de Enfermedad , Inhibidores Enzimáticos/toxicidad , Femenino , Radical Hidroxilo/metabolismo , Indazoles/toxicidad , Intoxicación del Sistema Nervioso por Plomo/fisiopatología , Microdiálisis , Óxido Nítrico/metabolismo , Estrés Oxidativo/fisiología , Corteza Prefrontal/efectos de los fármacos , Corteza Prefrontal/metabolismo , Corteza Prefrontal/fisiopatología , Embarazo , Efectos Tardíos de la Exposición Prenatal/fisiopatología , Ratas , Ratas Wistar , Salicilatos/metabolismo , Transmisión Sináptica/efectos de los fármacos
4.
Toxicology ; 246(1): 83-9, 2008 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-18281141

RESUMEN

The present study was designed to explore the role of ontogenetic lead (Pb(2+)) exposure on a putative dopaminergic-nitrergic interaction in the nigrostriatal pathway. Pregnant Wistar rats were given tap water containing 250-ppm lead acetate, for the duration of pregnancy, with regular tap water (without Pb(2+)) being substituted at birth. Control rats were derived from dams that consumed tap water throughout pregnancy, and had no exposure to Pb(2+) afterwards. At 12 weeks after birth in vivo microdialysis of the neostriatum was employed to demonstrate that maternal Pb(2+) exposure was without effect on the baseline dopamine (DA) microdialysate concentration as well as amphetamine (AMPH, 1.0mg/kg i.p.)-evoked release of striatal DA. Also, prenatal Pb(2+) exposure did not enhance AMPH- and 7-nitroindazole (neuronal nitric oxide synthase inhibitor) (7-NI, 20mg/kg i.p.)-induced hydroxyl radical (HO) formation in the striatum, as indicated by analysis of the salicylate spin-trap product 2,5-dihydroxybenzoic acid. However, in rats exposed prenatally to Pb(2+), the facilitatory effect of 7-NI on DA exocytosis was attenuated. On the basis of the current study we conclude that maternal Pb(2+) exposure distorts the dopaminergic-nitrergic interaction in the nigrostriatal pathway, but without involvement of reactive oxygen species (ROS).


Asunto(s)
Anfetamina/metabolismo , Anfetamina/farmacología , Dopaminérgicos/metabolismo , Dopamina/metabolismo , Inhibidores Enzimáticos/farmacología , Radical Hidroxilo/metabolismo , Indazoles/farmacología , Plomo/toxicidad , Neostriado/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Animales , Femenino , Plomo/administración & dosificación , Microdiálisis , Neostriado/metabolismo , Embarazo , Efectos Tardíos de la Exposición Prenatal , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA